LOGO
SUBSCRIBE NOW

Week 1

IV. Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation
11
Jan
117

Please summarise this article What is the level of evidence provided by this article? What are the weaknesses and strengths of this study?   View / Download

Posted in: Post-transplant Long-term Complications , Week 1 ,
III. De Novo Malignancies after Kidney Transplantation
11
Jan
122

Please summarise this article What is the level of evidence provided by this article   View / Download

Posted in: Post-transplant Long-term Complications , Week 1 ,
II. Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit
11
Jan
135

Please summarise this article What is the level of evidence provided by this article? What are the drawbacks when we use the registry data?   View / Download

Posted in: Post-transplant Long-term Complications , Week 1 ,
I. Behavioural and pharmaceutical interventions for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomised controlled trials
11
Jan
129

Please summarise this article What is the level of evidence provided by this article? What is the difference between bias and errors? View / Download

Posted in: Post-transplant Long-term Complications , Week 1 ,
5. A 46-year-old CKD 5 patient who was on HD for 4 years secondary to unknown aetiology presented to you in the transplant clinic 3 years after his transplantation with this lesion on the right side of his neck (see below). He is currently on tacrolimus-based immunosuppression with excellent kidney function.
11
Jan
149

What is your differential diagnosis? Briefly outline his management  

Posted in: Post-transplant Long-term Complications , Week 1 ,
4. A 51-year-old CKD 5 patient on HD for the last 4 years secondary to IgAN presented to you in the transplant assessment clinic to consider suitability for kidney transplantation. His brother is willing to donate a kidney for him, 000 mismatch and no DSA. On routine examination this lesion was identified which developed 6 weeks ago
11
Jan
148

What is your differential diagnosis? Council this patient regarding kidney transplantation? What is your workup strategy?  

Posted in: Post-transplant Long-term Complications , Week 1 ,
3. A 46-year-old CKD 5 Afro-Caribbean on HD for the last 4 years secondary to IgAN presented to you in the transplant assessment clinic to consider suitability for kidney transplantation. His brother is willing to donate a kidney for him, 000 mismatch and no DSA. On routine examination this lesion was identified
11
Jan
157

What is your differential diagnosis? Council this patient regarding kidney transplantation? What is your workup strategy?  

Posted in: Post-transplant Long-term Complications , Week 1 ,
2. A 36-year-old kidney transplant recipient developed this lesion 14 years after his cadaveric transplantation. Currently, he is on Tacrolimus (trough level 8.3 ng/ml) and MMF 500 mg bd. He has excellent kidney function (S Cr is 113 µmol/L).
11
Jan
192

What is your differential diagnosis? How do you manage this case? Substantiate your answer.  

Posted in: Post-transplant Long-term Complications , Week 1 ,
1. A 31-year-old CKD 5 patient due to FSGS received a kidney offer from a deceased 29-year-old donor.
11
Jan
195

Comment on the report. Comment on the difference between the broad and the split mismatch. What is the impact of split mismatch on graft survival? Explain how the presence of DSA influences graft survival would. Will you proceed with the transplantation? If yes, what is your immunosuppression protocol? If not, what are the other options? […]

Posted in: Post-transplant Long-term Complications , Week 1 ,
LOGO

Credit To

ICOM

Follow Us

Copyright © 2024 World Kidney Academy. All Rights Reserved. ICOM